1. Home
  2. MPLT vs QCRH Comparison

MPLT vs QCRH Comparison

Compare MPLT & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$11.75

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo QCR Holdings Inc.

QCRH

QCR Holdings Inc.

HOLD

Current Price

$106.56

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
QCRH
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
MPLT
QCRH
Price
$11.75
$106.56
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$32.67
$98.25
AVG Volume (30 Days)
1.3M
96.8K
Earning Date
05-28-2026
04-22-2026
Dividend Yield
N/A
0.44%
EPS Growth
82.39
11.62
EPS
N/A
4.18
Revenue
N/A
$165,999,610.00
Revenue This Year
N/A
$8.46
Revenue Next Year
N/A
$5.59
P/E Ratio
N/A
$25.50
Revenue Growth
N/A
20.72
52 Week Low
$9.10
$66.71
52 Week High
$40.43
$106.68

Technical Indicators

Market Signals
Indicator
MPLT
QCRH
Relative Strength Index (RSI) 28.18 69.84
Support Level $9.10 $93.70
Resistance Level $20.73 $106.55
Average True Range (ATR) 1.49 1.95
MACD -0.16 0.13
Stochastic Oscillator 35.72 77.00

Price Performance

Historical Comparison
MPLT
QCRH

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.

Share on Social Networks: